Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates

BACKGROUND: Newborn screening (NBS) has been implemented for neonatal inborn disorders using various technology platforms, but false-positive and false-negative results are still common. In addition, target diseases of NBS are limited by suitable biomarkers. Here we sought to assess the feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xinwen, Wu, Dingwen, Zhu, Lin, Wang, Wenjun, Yang, Rulai, Yang, Jianbin, He, Qunyan, Zhu, Bingquan, You, Ying, Xiao, Rui, Zhao, Zhengyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862216/
https://www.ncbi.nlm.nih.gov/pubmed/35193651
http://dx.doi.org/10.1186/s13023-022-02231-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862216/
https://www.ncbi.nlm.nih.gov/pubmed/35193651
http://dx.doi.org/10.1186/s13023-022-02231-x

Ejemplares similares